Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 31;13(2):10-18.
eCollection 2018.

Achieving triple treatment goals in multi-ethnic Asian patients with type 2 diabetes mellitus in primary care

C C Goh  1 , K H Koh  2 , Scp Goh  3 , Yle Koh  4 , N C Tan  5
Affiliations

Achieving triple treatment goals in multi-ethnic Asian patients with type 2 diabetes mellitus in primary care

C C Goh et al. Malays Fam Physician. .

Abstract

Introduction: Achieving optimal glycated hemoglobin (HbA1c), blood pressure (BP), and LDL-Cholesterol (LDL-C) in patients mitigates macro- and micro-vascular complications, which is the key treatment goal in managing type 2 diabetes mellitus (T2DM). This study aimed to determine the proportion of patients in an urban community with T2DM and the above modifiable conditions attaining triple vascular treatment goals based on current practice guidelines.

Methods: A questionnaire was distributed to adult Asian patients with dyslipidemia at two primary care clinics (polyclinics) in northeastern Singapore. The demographic and clinical data for this sub-population with both T2DM and dyslipidemia were collated with laboratory and treatment information retrieved from their electronic health records. The combined data was then analyzed to determine the proportion of patients who attained triple treatment goals, and logistic regression analysis was used to identify factors associated with this outcome.

Results: 665 eligible patients [60.5% female, 30.5% Chinese, 35% Malays, and 34.4% Indians] with a mean age of 60.6 years were recruited. Of these patients, 71% achieved LDL-C ≤2.6 mmol/L, 70.4% had BP <l40/90 mmHg, and 40.9% attained HbAlc ≤7%. Overall, 22% achieved the triple treatment goals for glycemia, BP, and LDL-C control. The major determinants were the number of diabetic medications and intensity of statin therapy.

Conclusion: Eight in ten patients with T2DM failed to achieve concurrent glycemic, BP, and LDL-C treatment goals, subjecting them to risks of vascular complications. Primary healthcare professionals can mitigate these risks by optimizing therapeutic treatment to maximize glycemia, dyslipidemia, and BP control.

Keywords: LDL-Cholesterol; Type 2 diabetes mellitus; blood pressure; normoglycemia; treatment goals.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Venn diagram showing proportion of patients with T2DM attaining their glycemia, blood pressure, and LDL-Cholesterol treatment goals (n=665)
See this image and copyright information in PMC

References

    1. Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: The role of risk factors. Prev Cardiol. 2002;5(4):188–99. - PubMed
    1. Sarwar N, Gao P, Seshasai SRK, Gobin R, Kaptoge S, Di Angelantonio E. et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet Lond Engl. 2010 Jun 26;375(9733):2215–22. - PMC - PubMed
    1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998 Sep 12;317(7160):703–13. - PMC - PubMed
    1. Ray KK, Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D. et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet Lond Engl. 2009 May 23;373(9677):1765–72. - PubMed
    1. Papanas N, Maltezos E. Oral anti-diabetic agents: Anti-atherosclerotic properties beyond glucose lowering? Curr Pharm Des. 2009;15(27):3179–92. - PubMed

LinkOut - more resources